These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 28513288)

  • 1. Growth arrest-specific protein 6 (Gas6) as a noninvasive biomarker for early detection of diabetic nephropathy.
    Li W; Wang J; Ge L; Shan J; Zhang C; Liu J
    Clin Exp Hypertens; 2017; 39(4):382-387. PubMed ID: 28513288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of plasma growth arrest-specific protein 6 (Gas6) concentrations with albuminuria in patients with type 2 diabetes.
    Erek-Toprak A; Bingol-Ozakpinar O; Karaca Z; Cikrikcioglu MA; Hursitoglu M; Uras AR; Adeli K; Uras F
    Ren Fail; 2014 Jun; 36(5):737-42. PubMed ID: 24512357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary Cyclophilin A and serum Cystatin C as biomarkers for diabetic nephropathy in children with type 1 diabetes.
    Salem NA; El Helaly RM; Ali IM; Ebrahim HAA; Alayooti MM; El Domiaty HA; Aboelenin HM
    Pediatr Diabetes; 2020 Aug; 21(5):846-855. PubMed ID: 32304131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary heme oxygenase-1 as a potential biomarker for early diabetic nephropathy.
    Li Z; Xu Y; Liu X; Nie Y; Zhao Z
    Nephrology (Carlton); 2017 Jan; 22(1):58-64. PubMed ID: 26733347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The changes in miR-130b levels in human serum and the correlation with the severity of diabetic nephropathy.
    Lv C; Zhou YH; Wu C; Shao Y; Lu CL; Wang QY
    Diabetes Metab Res Rev; 2015 Oct; 31(7):717-24. PubMed ID: 25952368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystatin C as an early biomarker of nephropathy in patients with type 2 diabetes.
    Jeon YK; Kim MR; Huh JE; Mok JY; Song SH; Kim SS; Kim BH; Lee SH; Kim YK; Kim IJ
    J Korean Med Sci; 2011 Feb; 26(2):258-63. PubMed ID: 21286018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystatin C and cystatin glomerular filtration rate as markers of early renal disease in Asian Indian subjects with glucose intolerance (CURES-32).
    Surendar J; Anuradha S; Ashley B; Balasubramanyam M; Aravindhan V; Rema M; Mohan V
    Metab Syndr Relat Disord; 2009 Oct; 7(5):419-25. PubMed ID: 19419268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary podocalyxin positive-element occurs in the early stage of diabetic nephropathy and is correlated with a clinical diagnosis of diabetic nephropathy.
    Ye H; Bai X; Gao H; Li L; Wu C; Sun X; Zhang C; Shen Y; Zhang J; Lu Z
    J Diabetes Complications; 2014; 28(1):96-100. PubMed ID: 24075693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of serum miR-29a in the occurrence and progression of diabetic nephropathy: A cross-sectional study.
    Liu Q; Wang M; Xu T; Liang W; Yang F
    J Clin Lab Anal; 2022 Feb; 36(2):e24210. PubMed ID: 34964177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystatin-C and TGF-β levels in patients with diabetic nephropathy.
    Takir M; Unal AD; Kostek O; Bayraktar N; Demirag NG
    Nefrologia; 2016; 36(6):653-659. PubMed ID: 27745866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoinductive factor is a novel biomarker for the diagnosis of early diabetic nephropathy.
    Wang S; Wang Y; Zheng R; Zhao Z; Ma Y
    Int J Clin Exp Pathol; 2015; 8(3):3110-5. PubMed ID: 26045825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma type IV collagen levels as a potential biomarker for early detection of nephropathy in diabetes mellitus patients.
    Atita FA; El-Hagrasy HA; Hassan MM; Esawy HS
    Egypt J Immunol; 2024 Jul; 31(3):150-160. PubMed ID: 38996049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum cystatin C as a marker for early detection of chronic kidney disease and grade 2 nephropathy in Japanese patients with type 2 diabetes.
    Suzuki Y; Matsushita K; Seimiya M; Yoshida T; Sawabe Y; Ogawa M; Nomura F
    Clin Chem Lab Med; 2012 Oct; 50(10):1833-9. PubMed ID: 23089714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Clinical Value of Serum Adropin Level in Early Detection of Diabetic Nephropathy.
    Es-Haghi A; Al-Abyadh T; Mehrad-Majd H
    Kidney Blood Press Res; 2021; 46(6):734-740. PubMed ID: 34644709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of serum cystatin C and chromogranin A as markers of nephropathy in patients with type 2 diabetes mellitus.
    Mojiminiyi OA; Abdella N; George S
    Scand J Clin Lab Invest; 2000 Oct; 60(6):483-9. PubMed ID: 11129064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E-cadherin and periostin in early detection and progression of diabetic nephropathy: epithelial-to-mesenchymal transition.
    El-Dawla NMQ; Sallam AM; El-Hefnawy MH; El-Mesallamy HO
    Clin Exp Nephrol; 2019 Aug; 23(8):1050-1057. PubMed ID: 31104272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum osteoinductive factor is associated with microalbuminuria and diabetic nephropathy in type 2 diabetes.
    Wei W; Tu M; Huang R; Chen T
    Medicine (Baltimore); 2018 Aug; 97(31):e11759. PubMed ID: 30075597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus.
    Shoukry A; Bdeer Sel-A; El-Sokkary RH
    Mol Cell Biochem; 2015 Oct; 408(1-2):25-35. PubMed ID: 26104579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and Stratification of Diabetic Kidney Disease Using Serum Cystatin C and Serum Creatinine Based Estimating Equations in Type 2 Diabetes: A Comparative Analysis.
    Avinash S; Singh VP; Agarwal AK; Chatterjee S; Araya V
    J Assoc Physicians India; 2015 Nov; 63(11):28-35. PubMed ID: 29900708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum chromogranin A correlated with albuminuria in diabetic patients and is associated with early diabetic nephropathy.
    Yu H; Wang H; Su X; Cao A; Yao X; Wang Y; Zhu B; Wang H; Fang J
    BMC Nephrol; 2022 Jan; 23(1):41. PubMed ID: 35062888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.